SARS-CoV-2 3C-likease protein (Recombinant) (N-His&Avi) (STJP001273)
SPECIFICATIONS
HostE.coli
ConjugationUnconjugated
ImmunogenRecombinant SARS-CoV-2 (2019-nCoV) 3C-like Proteinase is produced by E. coli expression system. The target protein is expressed with sequence (Ser1-Gln306) of SARS-COV-2 (2019-nCoV) 3C-like Proteinase (Accession #YP_009725301.1) fused with an initial
General Information
| Short Description | Recombinant-SARS-CoV-2 3C-likease-N-His&Avi protein was developed in e.coli using the region Ser1-Gln306. For use in research applications. |
| Host | E.coli |
| Note | STRICTLY FOR FURTHER SCIENTIFIC RESEARCH USE ONLY (RUO). MUST NOT TO BE USED IN DIAGNOSTIC OR THERAPEUTIC APPLICATIONS. |
Product Properties
| Conjugation | Unconjugated |
| Formulation | Supplied as a 0.22 Mu m filtered solution in 20mM HEPES, 120mM NaCl, 10% Glycerol, 2mM TCEP, pH 7.4 |
| Storage Instruction | Store at-20Β°C for up to 1 year from the date of receipt, and avoid repeat freeze-thaw cycles. |
| Determination Method | < 1.0 EU/Mu g of the protein by LAL method. |
Target Information
| Immunogen | Recombinant SARS-CoV-2 (2019-nCoV) 3C-like Proteinase is produced by E. coli expression system. The target protein is expressed with sequence (Ser1-Gln306) of SARS-COV-2 (2019-nCoV) 3C-like Proteinase (Accession #YP_009725301.1) fused with an initial |
| Immunogen Region | Ser1-Gln306 |
| Immunogen Sequence | SGFRKMAFPSGKVEGCMVQV TCGTTTLNGLWLDDVVYCPR HVICTSEDMLNPNYEDLLIR KSNHNFLVQAGNVQLRVIGH SMQNCVLKLKVDTANPKTPK YKFVRIQPGQTFSVLACYNG SPSGVYQCAMRPNFTIKGSF LNGSCGSVGFNIDYDCVSFC YMHHMELPTGVHAGTDLEGN FYGPFVDRQTAQAAGTDTTI TVNVLAWLYAAVINGDRWFL NRFTTTLNDFNLVAMKYNY |
Additional Info
| Background | Recombinant SARS-CoV-2 (2019-nCoV) 3C-like Proteinase is produced by E. coli expression system. The target protein is expressed with sequence (Ser1-Gln306) of SARS-COV-2 (2019-nCoV) 3C-like Proteinase (Accession #YP_009725301.1) fused with an initial Met, a 6ΓHis, Avi tag at the N-terminus. |
Information sourced from Uniprot.org